Sense, antisense, nonsense: where's the right way?
Congress Report
Received:
Accepted:
- 22 Downloads
- 1 Citations
Abstract
The application of small nucleic acids is slowly moving from chemistry and molecular biology laboratories into the clinic. However, the development of a new family of therapeutics is always difficult. Research must be performed to produce chemically compatible compounds in vivo and pharmacological investigations are necessary to precisely define the in vivo mechanisms of action of these potentially new drugs. The “2nd International Conference on Antisense Nucleic Acids: Biology, Pharmacology, Therapy” held in Garmisch-Partenkirchen addressed these questions.
Key words
Antisense Oligonucleotide Gene inhibition Gene therapyPreview
Unable to display preview. Download preview PDF.
References
- 1.Weatherall DJ (1995) Scope and limitations of gene therapy. Br Med Bull 51:1–11Google Scholar
- 2.Sun JS, Helene C (1993) Oligonucleotide-directed triple-helix formation. Curr Op Struct Biol 3:345–356Google Scholar
- 3.Gosh MK, Cohen JS (1991) Oligodeoxynucleotides as antisense inhibitors of gene expression. Progr Nucleic Acid Res Mol Biol 42:79–126Google Scholar
- 4.Kiehntopf M, Esquivel EL, Brach MA, Hermann F (1995) Ribozymes: biology, biochemistry, and implications for clinical medicine. J Mol Med 73:65–71Google Scholar
- 5.Agrawal S, Temsamani J, Tang JY (1991) pharmacokinetics, biodistribution and stability of oligonucleotide phosphothioates in mice. Proc Natl Acad Sci USA 88:7595–7599PubMedGoogle Scholar
- 6.Stein CA and Krieg AM (1994) Problems in interpretation of data derived from in vitro and in vivo use of antisense Oligodeoxynucleotides. Antisense Res Dev 4: 67–69Google Scholar
- 7.Wagner RW (1994) Gene inhibition using antisense oligonucleotides. Nature 372: 333–335Google Scholar
- 8.Villa AE, Poptic EJ, Labhasetwar V, D'Souza S, Farrell CL, Plow EF, Levy RJ, DiCorletto PE, Topol EJ (1995) Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell roliferation and response to vessel wall injury. Circ Res 76:505–513Google Scholar
- 9.Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Sqinto SP, Yancopoulos GD, Lindsay RM (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374:450–453CrossRefPubMedGoogle Scholar
- 10.Black LE, Farelly JG, Cavagnaro JA, Ahn CO, DeGeorge JJ, Taylor AS, DeFelice AF, Jordan M (1994) Regulatory considerations for oligonucleotide drugs: updated recommendations for pharmacology and toxicological studies. Antisense Res Dev 4: 299–301Google Scholar
- 11.Cornish KG, Iversen P, Smith L, Arneson M, Bayever E (1993) Cardiovascular effects of a phosphothioate oligonucleotide with sequence antisense to p53 in the conscious rhesus monkey. Antisense Res Dev 3:201–247Google Scholar
- 12.Galbraith WM, Hobson WC, Giclas PC, Schechter PJ, Agrawal S (1994) Complement activation and hemodynamic changes following intravenous administration of phosphothioate oligonucleotides in the monkey. Antisense Res Dev 4:201–207Google Scholar
Copyright information
© Springer-Verlag 1995